Why did Trump's tariffs push some companies closer to default?
How will Union Pacific's potential Norfolk Southern merger impact railroads?
What caused Netflix's latest earnings surge despite stock dip?
Why is Coca-Cola considering cane sugar over corn syrup?
How does the GENIUS Act affect cryptocurrency regulation?
What are the risks if Trump fires Fed Chair Powell?
Why did Meta settle the $8 billion Facebook privacy lawsuit?
Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off
benzinga.com/news/health-care/25/07/46478200/bristol%E2%80%91myers-squibb-pfizer-set-to-launch-direct%E2%80%91to%E2%80%91patient-eliquis-at-40-off
The Bristol Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) alliance announced a new direct-to-patient option for purchasing Eliquis (apixaban) via the alliance’s patient resource, Eliquis 360 Support, on Thursday.
Eliquis is a blood-thinning medication that reduces blood clotting…
This story appeared on benzinga.com, 2025-07-17 18:55:48.